ReviewMolecular diagnosis & therapy2012

Individualized therapy for gastroesophageal reflux disease: potential impact of pharmacogenetic testing based on CYP2C19.

Takahisa Furuta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.